文献速递胃肠外科围术期管理与 ERAS

袖状胃切除术降低病态肥胖患者可溶性LOX-1水平

Original contribution: sleeve gastrectomy reduces soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) levels in patients with morbid obesity.
PubMed 文献 · Surg Endosc · 2022-01-19

该研究比较了袖状胃切除术(SG)组与健康对照组基线及术后12个月的代谢与炎症指标,发现SG组基线指标显著异常,术后大部分指标显著下降并趋近对照组;基线白蛋白及oxLDL和CRF的降低百分比与sLOX-1降低百分比显著相关。结论提示SG减重可能通过降低oxLDL和LOX-1水平限制内皮损伤。

要点

  • SG组术后12个月平均BMI降低-11.8±9.0(p<0.001),大部分代谢与炎症指标显著下降。
  • 基线白蛋白及oxLDL和CRF的降低百分比与sLOX-1降低百分比显著相关。
  • sLOX-1可能作为病态肥胖患者动脉粥样硬化疾病状态的标志物。

核心结论

  • SG减重后基线升高的代谢与炎症生物标志物显著下降。
  • SG诱导的减重可能通过降低oxLDL和LOX-1(以sLOX-1评估)水平限制内皮损伤。
  • sLOX-1可能作为病态肥胖患者动脉粥样硬化疾病状态的标志物,代谢/减重手术可能在CVD预防中起有意义的作用。

研究设计与样本

  • 研究纳入SG手术组(n=20)和健康对照组(n=20),在基线及SG术后12个月测量BMI并检测代谢与炎症标志物。
  • 比较两组基线及术后指标,并分析这些参数变化与sLOX-1变化的相关性。

主要发现

  • 基线时手术组与对照组的代谢和炎症标志物值显著不同(p<0.001)。
  • 术后12个月手术组大部分生物标志物水平显著下降,平均BMI降低-11.8±9.0(p<0.001),趋近对照组值。
  • 基线白蛋白水平以及oxLDL和胆固醇保留分数(CRF)的降低百分比与SG术后12个月sLOX-1降低百分比显著相关。

临床怎么用

  • 对于病态肥胖患者,SG术后减重可显著改善代谢与炎症生物标志物。
  • sLOX-1可能作为评估病态肥胖患者动脉粥样硬化疾病状态的标志物。
  • 代谢/减重手术可能在心血管疾病预防中起有意义的作用。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Early diagnosis of subclinical cardiovascular disease (CVD) in patients with morbid obesity is important. We investigated the effects of sleeve gastrectomy (SG) on serum soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1), oxidized LDL (oxLDL), and other metabolic and inflammatory parameters associated with atherosclerosis in patients with morbid obesity. METHODS: Body mass index (BMI) measurements and assays of metabolic and inflammatory markers were taken in patients in an SG surgery group and a healthy control group and compared at baseline and 12 months after SG. Correlations with changes in these parameters and variations in sLOX-1 were analyzed. RESULTS: Metabolic and inflammatory marker values in the surgery (n = 20) and control (n = 20) groups were significantly different at baseline (p < 0.001). The majority of surgery group biomarker levels significantly decreased with mean BMI loss (- 11.8 ± 9.0, p < 0.001) at 12 months, trending toward control group values. Baseline albumin level as well as percentage reductions in oxLDL and the cholesterol retention fraction (CRF) were found to be significantly correlated with percentage reduction in sLOX-1 at 12 months following SG. CONCLUSION: Metabolic and inflammatory biomarkers elevated at baseline significantly decreased after SG weight loss. Weight loss induced by SG may limit endothelial damage by reducing levels of oxLDL and LOX-1 as assessed by sLOX-1. These findings suggest that sLOX-1 may function as a marker of atherosclerotic disease states in patients with morbid obesity and that metabolic/bariatric surgery can play a meaningful role in CVD prevention.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Taskin HE, Kocael A, Kocael P, et al. Original contribution: sleeve gastrectomy reduces soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) levels in patients with morbid obesity. Surg Endosc. 2022. PMID: 35044516. doi:10.1007/s00464-021-08989-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。